The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Anthelmin Plus XL Tablets for dogs

525, 504, 175 mg/tablet Tablet

Krka, d.d., Novo mestoVPA10774/033/002

Main Information

Trade NameAnthelmin Plus XL Tablets for dogs
Active SubstancesFebantel
Pyrantel embonate
Strength525, 504, 175 mg/tablet
Dosage FormTablet
Licence HolderKrka, d.d., Novo mesto
Licence NumberVPA10774/033/002

Group Information

ATC CodeQP52AC55 febantel, combinations
Therapeutic ClassEndoparasiticide


Licence Issued01/05/2015
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back